153 related articles for article (PubMed ID: 21271713)
1. Functionalization of osmium arene anticancer complexes with (poly)arginine: effect on cellular uptake, internalization, and cytotoxicity.
Rijt SH; Kostrhunova H; Brabec V; Sadler PJ
Bioconjug Chem; 2011 Feb; 22(2):218-26. PubMed ID: 21271713
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity.
Fu Y; Habtemariam A; Basri AM; Braddick D; Clarkson GJ; Sadler PJ
Dalton Trans; 2011 Oct; 40(40):10553-62. PubMed ID: 21860862
[TBL] [Abstract][Full Text] [Related]
3. Organometallic osmium(II) arene anticancer complexes containing picolinate derivatives.
van Rijt SH; Peacock AF; Johnstone RD; Parsons S; Sadler PJ
Inorg Chem; 2009 Feb; 48(4):1753-62. PubMed ID: 19146436
[TBL] [Abstract][Full Text] [Related]
4. Tuning the reactivity of osmium(II) and ruthenium(II) arene complexes under physiological conditions.
Peacock AF; Habtemariam A; Fernández R; Walland V; Fabbiani FP; Parsons S; Aird RE; Jodrell DI; Sadler PJ
J Am Chem Soc; 2006 Feb; 128(5):1739-48. PubMed ID: 16448150
[TBL] [Abstract][Full Text] [Related]
5. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
Peacock AF; Parsons S; Sadler PJ
J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
[TBL] [Abstract][Full Text] [Related]
6. DNA interactions of monofunctional organometallic osmium(II) antitumor complexes in cell-free media.
Kostrhunova H; Florian J; Novakova O; Peacock AF; Sadler PJ; Brabec V
J Med Chem; 2008 Jun; 51(12):3635-43. PubMed ID: 18494458
[TBL] [Abstract][Full Text] [Related]
7. Photoactivated Osmium Arene Anticancer Complexes.
Xue X; Fu Y; He L; Salassa L; He LF; Hao YY; Koh MJ; Soulié C; Needham RJ; Habtemariam A; Garino C; Lomachenko KA; Su Z; Qian Y; Paterson MJ; Mao ZW; Liu HK; Sadler PJ
Inorg Chem; 2021 Dec; 60(23):17450-17461. PubMed ID: 34503331
[TBL] [Abstract][Full Text] [Related]
8. In-Cell Activation of Organo-Osmium(II) Anticancer Complexes.
Needham RJ; Sanchez-Cano C; Zhang X; Romero-Canelón I; Habtemariam A; Cooper MS; Meszaros L; Clarkson GJ; Blower PJ; Sadler PJ
Angew Chem Int Ed Engl; 2017 Jan; 56(4):1017-1020. PubMed ID: 28000997
[TBL] [Abstract][Full Text] [Related]
9. Cancer cell cytotoxicity of cyclometalated compounds obtained with osmium(II) complexes.
Boff B; Gaiddon C; Pfeffer M
Inorg Chem; 2013 Mar; 52(5):2705-15. PubMed ID: 23427955
[TBL] [Abstract][Full Text] [Related]
10. Osmium-arene complexes with high potency towards Mycobacterium tuberculosis.
Coverdale JPC; Guy CS; Bridgewater HE; Needham RJ; Fullam E; Sadler PJ
Metallomics; 2021 Apr; 13(4):. PubMed ID: 33693931
[TBL] [Abstract][Full Text] [Related]
11. In Vivo Selectivity and Localization of Reactive Oxygen Species (ROS) Induction by Osmium Anticancer Complexes That Circumvent Platinum Resistance.
Coverdale JPC; Bridgewater HE; Song JI; Smith NA; Barry NPE; Bagley I; Sadler PJ; Romero-Canelón I
J Med Chem; 2018 Oct; 61(20):9246-9255. PubMed ID: 30230827
[TBL] [Abstract][Full Text] [Related]
12. Structure-activity relationships for osmium(II) arene phenylazopyridine anticancer complexes functionalised with alkoxy and glycolic substituents.
Needham RJ; Bridgewater HE; Romero-Canelón I; Habtemariam A; Clarkson GJ; Sadler PJ
J Inorg Biochem; 2020 Sep; 210():111154. PubMed ID: 32771772
[TBL] [Abstract][Full Text] [Related]
13. Amide linkage isomerism as an activity switch for organometallic osmium and ruthenium anticancer complexes.
van Rijt SH; Hebden AJ; Amaresekera T; Deeth RJ; Clarkson GJ; Parsons S; McGowan PC; Sadler PJ
J Med Chem; 2009 Dec; 52(23):7753-64. PubMed ID: 19791745
[TBL] [Abstract][Full Text] [Related]
14. Design of Ru-arene Complexes for Antitumor Drugs.
Su W; Li Y; Li P
Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728
[TBL] [Abstract][Full Text] [Related]
15. Hydrolysis and cytotoxic properties of osmium(II)/(III)-DMSO-azole complexes. Short communication.
Egger A; Cebrián-Losantos B; Stepanenko IN; Krokhin AA; Eichinger R; Jakupec MA; Arion VB; Keppler BK
Chem Biodivers; 2008 Aug; 5(8):1588-1593. PubMed ID: 18729098
[TBL] [Abstract][Full Text] [Related]
16. Precious metal carborane polymer nanoparticles: characterisation of micellar formulations and anticancer activity.
Barry NP; Pitto-Barry A; Romero-Canelón I; Tran J; Soldevila-Barreda JJ; Hands-Portman I; Smith CJ; Kirby N; Dove AP; O'Reilly RK; Sadler PJ
Faraday Discuss; 2014; 175():229-40. PubMed ID: 25270092
[TBL] [Abstract][Full Text] [Related]
17. Ternary dinuclear copper(II) complexes of a hydroxybenzamide ligand with diimine coligands: the 5,6-dmp ligand enhances DNA binding and cleavage and induces apoptosis.
Ramakrishnan S; Shakthipriya D; Suresh E; Periasamy VS; Akbarsha MA; Palaniandavar M
Inorg Chem; 2011 Jul; 50(14):6458-71. PubMed ID: 21671566
[TBL] [Abstract][Full Text] [Related]
18. Derivation of structure-activity relationships from the anticancer properties of ruthenium(II) arene complexes with 2-aryldiazole ligands.
Martínez-Alonso M; Busto N; Jalón FA; Manzano BR; Leal JM; Rodríguez AM; García B; Espino G
Inorg Chem; 2014 Oct; 53(20):11274-88. PubMed ID: 25302401
[TBL] [Abstract][Full Text] [Related]
19. Pharmaco-genomic investigations of organo-iridium anticancer complexes reveal novel mechanism of action.
Hearn JM; Hughes GM; Romero-Canelón I; Munro AF; Rubio-Ruiz B; Liu Z; Carragher NO; Sadler PJ
Metallomics; 2018 Jan; 10(1):93-107. PubMed ID: 29131211
[TBL] [Abstract][Full Text] [Related]
20. Mirror-image organometallic osmium arene iminopyridine halido complexes exhibit similar potent anticancer activity.
Fu Y; Soni R; Romero MJ; Pizarro AM; Salassa L; Clarkson GJ; Hearn JM; Habtemariam A; Wills M; Sadler PJ
Chemistry; 2013 Nov; 19(45):15199-209. PubMed ID: 24114923
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
